GPX Medical is one of several successful spin-off companies from Biophotonics in Lund, addressing the needs of better care for our patients.

On April 5th 2019 GPX Medical, represented by Chairman of the Board Märta Lewander Xu, CEO Hanna Sjöström and CTO Sara Bergsten, participated in a workshop held by Lund University Medical Lacer Center’s manager Professor Bo Baldetorp, Chairman of the Board Professor Katarina Svanberg and Professor Sune Svanberg, with the aim of understanding the challenges clinicians face today which needs tomorrow’s advanced solutions.

About GPX Medical

GPX Medical AB was formed in 2016 as a subsidiary to Gasporox AB (publ) with the aim to develop and commercialize medical applications of the GASMAS technology. The company is owned by Gasporox AB (publ) to 53,3%, by Norsk Elektro Optikk AS to 36,2% and by the team to 10,5%. The company is located in Lund, Sweden. Org. nbr. 559069-9012.

For investors

Please contact CEO Hanna Sjöström for investment opportunities:


GPX Medical AB
Tellusgatan 13
224 57 Lund